These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 8164315)
1. Use of sodium to clear partially occluded vascular access ports. Pennington CR; Johnston DA JPEN J Parenter Enteral Nutr; 1994; 18(1):90. PubMed ID: 8164315 [No Abstract] [Full Text] [Related]
2. Use of sodium hydroxide solution to clear partially occluded vascular access ports. ter Borg F; Timmer J; de Kam SS; Sauerwein HP JPEN J Parenter Enteral Nutr; 1993; 17(3):289-91. PubMed ID: 8505838 [TBL] [Abstract][Full Text] [Related]
3. Study of access recirculation in reversed temporary indwelling catheters. Laurin L; Twolan C J CANNT; 1994; 4(2):11-2. PubMed ID: 7999476 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of 6 years use of sodium hydroxide solution to clear partially occluded central venous catheters. Bader SG; Balke P; Jonkers-Schuitema CF; Tas TA; Sauerwein HP Clin Nutr; 2007 Feb; 26(1):141-4. PubMed ID: 17097197 [TBL] [Abstract][Full Text] [Related]
5. The mystery of the occluded port that allowed blood withdrawal: is it safe to use standard needles to access ports? A case report and literature review. Cataldo R; Costa F; Vitiello M; Brescia F; Proscia P; Falco C; Carassiti M J Surg Oncol; 2014 Apr; 109(5):500-3. PubMed ID: 24310214 [TBL] [Abstract][Full Text] [Related]
6. Effects of different rinsing regimen on totally implantable vascular access after 70 days infusion of total parenteral nutrition in vitro. Klem W; Bentdal EH; Flaatten H; With K JPEN J Parenter Enteral Nutr; 1987; 11(6):566-8. PubMed ID: 3123727 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. Deitcher SR; Fesen MR; Kiproff PM; Hill PA; Li X; McCluskey ER; Semba CP; J Clin Oncol; 2002 Jan; 20(1):317-24. PubMed ID: 11773185 [TBL] [Abstract][Full Text] [Related]
9. Use of hydrochloric acid to restore patency in an occluded implantable port: a case report. Kupensky DT J Intraven Nurs; 1995; 18(4):198-201. PubMed ID: 7629640 [TBL] [Abstract][Full Text] [Related]
10. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of the survival of permanent vascular access ports]. Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307 [TBL] [Abstract][Full Text] [Related]
12. [Long-term experiences with central venous catheters in pediatric oncology]. Hadjilaskari P; Brühmüller S; Fengler R; Hartmann R; Waldschmidt J; Henze G Monatsschr Kinderheilkd; 1990 Jan; 138(1):26-30. PubMed ID: 2107396 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Bertoglio S; Solari N; Meszaros P; Vassallo F; Bonvento M; Pastorino S; Bruzzi P Cancer Nurs; 2012; 35(4):E35-42. PubMed ID: 22228390 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters. Fetzer SJ; Manning GP Appl Nurs Res; 2004 Nov; 17(4):297-300. PubMed ID: 15573339 [TBL] [Abstract][Full Text] [Related]
17. Arm ports provide long-term central venous access. Sawhney R Diagn Imaging (San Franc); 1998 Oct; 20(10):59-61. PubMed ID: 10187441 [No Abstract] [Full Text] [Related]
18. Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study. Aspalter M; Lechner M; Linni K; Hitzl W; Hölzenbein T; Ofner D; Emmanuel K Am Surg; 2014 Feb; 80(2):204-7. PubMed ID: 24480224 [No Abstract] [Full Text] [Related]
19. A prospective observational study on 249 subcutaneous central vein access ports in a Swedish county hospital. Taxbro K; Berg S; Hammarskjöld F; Hanberger H; Malmvall BE Acta Oncol; 2013 Jun; 52(5):893-901. PubMed ID: 23432403 [TBL] [Abstract][Full Text] [Related]
20. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Haire WD; Deitcher SR; Mullane KM; Jaff MR; Firszt CM; Schulz GA; Schuerr DM; Schwartz LB; Mouginis TL; Barton RP Thromb Haemost; 2004 Sep; 92(3):575-82. PubMed ID: 15351854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]